Status:
WITHDRAWN
Vaping-Related Seizures - A Prospective Study
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Evaluate the Association of Vaping With Seizures
Eligibility:
All Genders
21+ years
Brief Summary
This case-crossover study evaluates the association between vaping and seizures in patients of a large academic medical center who admits to vaping and hav a planned ambulatory EEG ordered.
Detailed Description
This case-crossover study will evaluate the short-term effects (seizures) of intermittent exposure to vaping nicotine and/or marijuana products among Dartmouth Hitchcock Medical Center (DHMC) patients...
Eligibility Criteria
Inclusion
- Inclusion criteria includes any DHMC patient who admits to vaping and has a planned ambulatory EEG of any duration, regardless of diagnosis or reason for study.
Exclusion
- Exclusion criteria will include subjectively admitting to using any illicit drugs other than cannabinoids since within 7 days of the study and/or anyone who denies smoking since it would be an ethical issue having someone smoke for the first time during a research study.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06006442
Start Date
September 1 2023
End Date
May 31 2024
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756